CompletedNot applicableNCT01529450
Pilot LDE225 in Locally Advanced or Metastatic BCC + Previously Tx Non-LDE225 Smoothened Inhibitors
Studying Intraoral basal cell carcinoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Anne Chang
- Principal Investigator
- Anne Chang, MDStanford University
- Intervention
- LDE225(drug)
- Enrollment
- 11 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2012 – 2013
Study locations (1)
- Stanford University, School of Medicine, Stanford, California, United States
Collaborators
Novartis
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01529450 on ClinicalTrials.gov